USPTO serial 88707389
QUIKRES
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- GADSON, SHARI B.
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with QUIKRES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
New York, NY
New York, NY
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard A. Friedman
Richard A. Friedman PFIZER INC.235 EAST 42ND STREETNEW YORK, NY 10017UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Pharmaceutical preparations namely, narcotic antagonists; Pharmaceutical preparations namely, opioid antagonists; Syringes sold filled with pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Syringes sold filled with pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Syringes sold filled with narcotic antagonists; Syringes sold filled with opioid antagonists; Injectors sold filled with pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Injectors sold filled with pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Injectors sold filled with narcotic antagonists; Injectors sold filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose and addiction; Injectable pharmaceuticals for use in the treatment of substance abuse disorders, addiction, and overdose; Injectable pharmaceuticals namely, narcotic antagonists; Injectable pharmaceuticals namely, opioid antagonists | ACTIVE | — |
| 010 | Syringes for pharmaceutical preparations; Injectors for pharmaceutical preparations; Syringes for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 12, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 12, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 28, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 28, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 28, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 3, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 2, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 2, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 24, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Oct 24, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 14, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 12, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Apr 12, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Apr 12, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 30, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 28, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 28, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Sep 28, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 7, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 5, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 5, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 5, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 30, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 28, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 28, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 28, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 12, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 17, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 17, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 26, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 10, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jan 30, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 27, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 27, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 27, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 27, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 22, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 12, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 29, 2019 | NWAP | NEW APPLICATION ENTERED | — |